Faculty

Bruce R. Bacon, MD

Professor of Internal Medicine, Saint Louis University School of Medicine, St. Louis, Missouri

Disclosures

Disclosure: Bruce R. Bacon, MD, has disclosed the following relevant financial relationships:
Served as an advisor or consultant for: Merck & Co., Inc.; Gilead Sciences, Inc.; Bristol-Myers Squibb Company; Kadmon Pharmaceuticals; AbbVie, Inc.; Janssen Pharmaceuticals, Inc.
Served as a speaker or a member of a speakers bureau for: Merck & Co., Inc; Gilead Sciences, Inc.; Kadmon Pharmaceuticals; AbbVie, Inc.; Salix Pharmaceuticals, Inc.; Janssen Pharmaceuticals, Inc.
Received grants for clinical research from: Merck & Co., Inc.; Gilead Sciences, Inc.; Kadmon Pharmaceuticals; AbbVie, Inc.

Dr Bacon does not intend to discuss off-label uses of drugs, mechanical devices, biologics, or diagnostics approved by the FDA for use in the United States.

Dr Bacon does not intend to discuss investigational drugs, mechanical devices, biologics, or diagnostics not approved by the FDA for use in the United States.

Steven Flamm, MD

Chief, Transplant Hepatology; Professor of Medicine, Northwestern Medicine, Chicago, Illinois

Disclosures

Disclosure: Steven Flamm, MD, has disclosed the following relevant financial relationships:
Served as an advisor or consultant for: AbbVie, Inc.; Bristol-Myers Squibb Company; Gilead Sciences, Inc.; Merck & Co., Inc.
Served as a speaker or a member of a speakers bureau for: AbbVie, Inc.; Bristol-Myers Squibb Company; Gilead Sciences, Inc.; Merck & Co., Inc.
Received grants for clinical research from: AbbVie, Inc.; Gilead Sciences, Inc.

Dr Flamm does not intend to discuss off-label uses of drugs, mechanical devices, biologics, or diagnostics approved by the FDA for use in the United States.

Dr Flamm does not intend to discuss investigational drugs, mechanical devices, biologics, or diagnostics not approved by the FDA for use in the United States.

Editors

Douglas Blevins, MD

Scientific Director, Medscape, LLC

Disclosures

Disclosure: Douglas Blevins, MD, has disclosed no relevant financial relationships.

Terra M. Sumstine

Senior Medical Editor/Writer, Chichester Associates, Allendale, New Jersey

Disclosures

Disclosure: Terra M. Sumstine has disclosed no relevant financial relationships.

CME Reviewer

Robert Morris, PharmD

Associate CME Clinical Director, Medscape, LLC

Disclosures

Disclosure: Robert Morris, PharmD, has disclosed no relevant financial relationships.

Peer Reviewer

This activity has been peer reviewed and the reviewer has disclosed no relevant financial relationships.

CME / ABIM MOC

Targeted Care in HCV

Authors: Bruce R. Bacon, MD; Steven Flamm, MD
CME / ABIM MOC Released: 3/14/2017
THIS ACTIVITY HAS EXPIRED FOR CREDIT
Valid for credit through: 3/14/2018, 11:59 PM EST

Start Activity

Target Audience and Goal Statement

This activity is intended for gastroenterologists, primary care physicians, and infectious disease/HIV specialists.

The goal of this activity is to build healthcare professionals’ confidence in strategies for the individualized treatment, care coordination, and follow-up of the patient with chronic hepatitis C infection and to ensure that updated and emerging best practices are applied across a variety of clinical presentations.

Upon completion of this activity, participants will be able to:

Perform appropriate initial evaluation and testing in patients newly diagnosed with hepatitis C virus (HCV)
Perform appropriate baseline evaluation and testing in patients with HCV who are re-entering care
Apply the latest guidelines and available best evidence for the treatment of patients with chronic HCV infection
Individualize therapy based on patient-specific characteristics

Faculty

Bruce R. Bacon, MD

Professor of Internal Medicine, Saint Louis University School of Medicine, St. Louis, Missouri

Disclosures

Disclosure: Bruce R. Bacon, MD, has disclosed the following relevant financial relationships:
Served as an advisor or consultant for: Merck & Co., Inc.; Gilead Sciences, Inc.; Bristol-Myers Squibb Company; Kadmon Pharmaceuticals; AbbVie, Inc.; Janssen Pharmaceuticals, Inc.
Served as a speaker or a member of a speakers bureau for: Merck & Co., Inc; Gilead Sciences, Inc.; Kadmon Pharmaceuticals; AbbVie, Inc.; Salix Pharmaceuticals, Inc.; Janssen Pharmaceuticals, Inc.
Received grants for clinical research from: Merck & Co., Inc.; Gilead Sciences, Inc.; Kadmon Pharmaceuticals; AbbVie, Inc.

Dr Bacon does not intend to discuss off-label uses of drugs, mechanical devices, biologics, or diagnostics approved by the FDA for use in the United States.

Dr Bacon does not intend to discuss investigational drugs, mechanical devices, biologics, or diagnostics not approved by the FDA for use in the United States.

Steven Flamm, MD

Chief, Transplant Hepatology; Professor of Medicine, Northwestern Medicine, Chicago, Illinois

Disclosures

Disclosure: Steven Flamm, MD, has disclosed the following relevant financial relationships:
Served as an advisor or consultant for: AbbVie, Inc.; Bristol-Myers Squibb Company; Gilead Sciences, Inc.; Merck & Co., Inc.
Served as a speaker or a member of a speakers bureau for: AbbVie, Inc.; Bristol-Myers Squibb Company; Gilead Sciences, Inc.; Merck & Co., Inc.
Received grants for clinical research from: AbbVie, Inc.; Gilead Sciences, Inc.

Dr Flamm does not intend to discuss off-label uses of drugs, mechanical devices, biologics, or diagnostics approved by the FDA for use in the United States.

Dr Flamm does not intend to discuss investigational drugs, mechanical devices, biologics, or diagnostics not approved by the FDA for use in the United States.

Editors

Douglas Blevins, MD

Scientific Director, Medscape, LLC

Disclosures

Disclosure: Douglas Blevins, MD, has disclosed no relevant financial relationships.

Terra M. Sumstine

Senior Medical Editor/Writer, Chichester Associates, Allendale, New Jersey

Disclosures

Disclosure: Terra M. Sumstine has disclosed no relevant financial relationships.

CME Reviewer

Robert Morris, PharmD

Associate CME Clinical Director, Medscape, LLC

Disclosures

Disclosure: Robert Morris, PharmD, has disclosed no relevant financial relationships.

Peer Reviewer

This activity has been peer reviewed and the reviewer has disclosed no relevant financial relationships.

Accreditation Statements

Medscape, LLC is accredited by the American Nurses Credentialing Center (ANCC), the Accreditation Council for Pharmacy Education (ACPE), and the Accreditation Council for Continuing Medical Education (ACCME), to provide continuing education for the healthcare team.

For Physicians

Medscape, LLC designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit(s)™ . Physicians should claim only the credit commensurate with the extent of their participation in the activity.

ABIM MOC: PARS Activity Identifier 200814436

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.0 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. Aggregate participant data will be shared with commercial supporters of this activity.

Contact This Provider

For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]

Instructions for Participation and Credit

There are no fees for participating in or receiving credit for this online educational activity. For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.

This activity is designed to be completed within the time designated on the title page; physicians should claim only those credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the activity online during the valid credit period that is noted on the title page. To receive AMA PRA Category 1 Credit™, you must receive a minimum score of 70% on the post-test.

Follow these steps to earn CME/CE credit*:

Read the target audience, learning objectives, and author disclosures.
Study the educational content online or printed out.
Online, choose the best answer to each test question. To receive a certificate, you must receive a passing score as designated at the top of the test. We encourage you to complete the Activity Evaluation to provide feedback for future programming.

You may now view or print the certificate from your CME/CE Tracker. You may print the certificate but you cannot alter it. Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period you can print out the tally as well as the certificates from the CME/CE Tracker.

*The credit that you receive is based on your user profile.

processing....

ABOUT THIS ACTIVITY
Enhance your clinical skills as you engage with patients in an objective and realistic interactive simulation. Treat patients, diagnose medical conditions, and prescribe medications. There are no limits to your choices—order from thousands of labs, diagnoses, devices, and drugs using an intuitive patient chart-based interface.

Powerful metrics track your performance and provide instant expert feedback on your decisions. Upon completion, results will be presented, along with author commentary on each case.

Continue »

CME / ABIM MOC Information

Print
Like Tweet

Disclaimer

The educational activity presented above may involve simulated case-based scenarios. The patients depicted in these scenarios are fictitious and no association with any actual patient is intended or should be inferred.

The material presented here does not necessarily reflect the views of Medscape, LLC, or companies that support educational programming on medscape.org. These materials may discuss therapeutic products that have not been approved by the US Food and Drug Administration and off-label uses of approved products. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or employing any therapies described in this educational activity.

Faculty and Disclosures

Faculty

Bruce R. Bacon, MD

Steven Flamm, MD

Editors

Douglas Blevins, MD

Terra M. Sumstine

CME Reviewer

Robert Morris, PharmD

Peer Reviewer

CME / ABIM MOC

Targeted Care in HCV

Target Audience and Goal Statement

Faculty

Bruce R. Bacon, MD

Steven Flamm, MD

Editors

Douglas Blevins, MD

Terra M. Sumstine

CME Reviewer

Robert Morris, PharmD

Peer Reviewer

Accreditation Statements

For Physicians

Instructions for Participation and Credit

Targeted Care in HCV